P-110  SERUM KL-6 LEVELS IN LUNG CANCER

Tatsuya Yoshimasu, Shinji Maebeya, Shoji Oura, Takeshi Tamaki, Rie Nakamura, Yoshimitsu Hirai, Megumi Ohta, Miwako Miyasaka, Mitsumasa Kawago, Yoshitaka Okamura

Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University, Japan

P-111  The Prognostic Significance of FDG-PET in advanced NSCLC

Hun-Mo Ryoo, Sung Hwa Bae

Oncology, Internal Medicine, Daegu Catholic University Medical Center, Korea

P-112  Age at Diagnosis and Outcomes in Gefitinib-treated Female Patients with Non-small-cell Lung Cancer

Im Il Na, Du Hwan Choe, Jae Soo Koh, Jae Cheol Lee, Sung Hyun Yang

Korea Cancer Center Hospital, Korea

P-113  Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Terminally Ill Cancer Patients

Wanje Cho¹, Jae Yong Shim¹, Hye Ree Lee¹, Ga Hyun Son², Seung-Min Oh³

¹Department of Family Medicine, Yonsei University, Korea, ²Department of Obstetrics and Gynecology, Yonsei University, Korea, ³Department of Medical Education, Yonsei University, Korea

P-114  INDUCTION CHEMOTHERAPY WITH CYTARABIN AND MITOXANTRONE FOR ACUTE MYELOID LEUKEMIA IN FRIEBLE PATIENTS

Ghazaleh Shoja e Razavi, Alireza Goharian

Internal Medicine, Golestan University of Medicine, Iran

P-115  Immunophenotyping Assay of Acute Lymphoblastic Leukemia in Adults and it's Relation to Induction Therapy

Saied Hadi Chavoshi, Jamal Eivazi Ziaei, Ali Akbar Movasaghpour Akbari

Department of Hematology and Oncology, Tabriz University of Medical Sciences Hematology and Oncology Research Center, Islamic Republic of Iran

P-116  The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study

Sukjoong Oh¹, Jaehoon Lee²

¹Departement of Internal Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Korea, ²Gachon University, Gil Hospital, Department of Iternal Medicine, Korea

↑ Page Top